about
Cardiovascular magnetic resonance in myocarditis: A JACC White PaperPrevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprololRole of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology.Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imagingHypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy.Quantification of LV function and mass by cardiovascular magnetic resonance: multi-center variability and consensus contours.High Spatial Resolution Cardiovascular Magnetic Resonance at 7.0 Tesla in Patients with Hypertrophic Cardiomyopathy - First Experiences: Lesson Learned from 7.0 Tesla.Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing.Two-dimensional sixteen channel transmit/receive coil array for cardiac MRI at 7.0 T: design, evaluation, and applicationAssessment of the right ventricle with cardiovascular magnetic resonance at 7 TeslaHigh spatial resolution and temporally resolved T2* mapping of normal human myocardium at 7.0 Tesla: an ultrahigh field magnetic resonance feasibility study.Toward cardiovascular MRI at 7 T: clinical needs, technical solutions and research promisesAssessment of mitral bioprostheses using cardiovascular magnetic resonance.Refined approach for quantification of in vivo ischemia-reperfusion injury in the mouse heartAn open-source software tool for the generation of relaxation time maps in magnetic resonance imaging.Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications.The global cardiovascular magnetic resonance registry (GCMR) of the society for cardiovascular magnetic resonance (SCMR): its goals, rationale, data infrastructure, and current developmentsCardiac Involvement in Myotonic Dystrophy Type 2 Patients With Preserved Ejection Fraction: Detection by Cardiovascular Magnetic Resonance.Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart.In vitro assessment of heart valve bioprostheses by cardiovascular magnetic resonance: four-dimensional mapping of flow patterns and orifice area planimetry.Reduced oxygen uptake efficiency slope in patients with cardiac sarcoidosis.Cardiorespiratory fitness and insulin sensitivity in overweight or obese subjects may be linked through intrahepatic lipid content.Cost evaluation of cardiovascular magnetic resonance versus coronary angiography for the diagnostic work-up of coronary artery disease: application of the European Cardiovascular Magnetic Resonance registry data to the German, United Kingdom, Swiss,Functional and morphological cardiac magnetic resonance imaging of mice using a cryogenic quadrature radiofrequency coilDetailing radio frequency heating induced by coronary stents: a 7.0 Tesla magnetic resonance study.The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance.Rapid parametric mapping of the longitudinal relaxation time T1 using two-dimensional variable flip angle magnetic resonance imaging at 1.5 Tesla, 3 Tesla, and 7 TeslaWhole-Body MR Imaging in the German National Cohort: Rationale, Design, and Technical Background.Prospective, randomized comparison of gadopentetate and gadobutrol to assess chronic myocardial infarction applying cardiovascular magnetic resonance.Current T₁ and T₂ mapping techniques applied with simple thresholds cannot discriminate acute from chronic myocadial infarction on an individual patient basis: a pilot study.Evaluation of Aortic Blood Flow and Wall Shear Stress in Aortic Stenosis and Its Association With Left Ventricular Remodeling.Relation between myocardial edema and myocardial mass during the acute and convalescent phase of myocarditis--a CMR study.Variability and homogeneity of cardiovascular magnetic resonance myocardial T2-mapping in volunteers compared to patients with edema.Integrated biomarkers in cardiomyopathies: cardiovascular magnetic resonance imaging combined with molecular and immunologic markers--a stepwise approach for diagnosis and treatment.Blood flow characteristics in the ascending aorta after TAVI compared to surgical aortic valve replacement.Advanced methods for quantification of infarct size in mice using three-dimensional high-field late gadolinium enhancement MRI.Long-lasting improvements in liver fat and metabolism despite body weight regain after dietary weight lossBlood flow characteristics in the ascending aorta after aortic valve replacement--a pilot study using 4D-flow MRI.Cardiac magnetic resonance in acute myocarditis and dilated cardiomyopathy.Cardiovascular magnetic resonance imaging of non-ischaemic heart disease: established and emerging applications.
P50
Q24654343-064B90F5-7822-4A01-A8B1-281C7D42B601Q26768272-443EC343-C725-413B-8EF1-661AE607F179Q28069234-1E2EFAC0-3981-4C36-93F2-20394B0DBC64Q28168468-48D364DD-4939-4FCF-B9B2-582B9864DB9EQ30278822-973FB877-B9E2-4D52-A74B-E8910C70897CQ30278953-41465972-CF55-4330-8301-F29D05C48E93Q30390279-4155DB18-E3FD-4748-8067-77D51511AAEAQ30418614-4B08B56B-D2AC-4991-91ED-BAFBA552F409Q30448712-81916CC2-02FF-4C12-93FC-D9DA95157872Q30455514-D9570DCF-7179-4AAC-8351-227141AED3D0Q30459820-8E654BB8-B78C-49E8-999F-663D356A063DQ30476882-8E57F2F1-087B-49ED-A5EF-FA0A6A40D40EQ30480590-09D83304-349A-47B9-B776-60A1DCA64CE6Q30492315-973241ED-3D63-45B1-B67E-B49C2F49075FQ30495959-F0675562-7B29-49AA-AF80-7E1B76797C8AQ30541197-963E6760-0C85-4639-8BE9-22B9E9A66120Q30838251-4ACDA856-EC48-4A5C-815A-1525980CAAD1Q31111604-E4F53B41-9A52-4C03-A98B-92019156A095Q33300381-5582EEC8-140E-42B9-AC8E-72B156D5D2E7Q33827144-F854154D-565C-4A73-9C39-37A4152B2310Q33910721-911AC606-98EF-4736-9606-8547F2089ADAQ33930226-2D8BED4C-DD12-4B54-A450-E55ED40AB107Q34304034-19935DC8-11C2-487C-837F-B708AF48BDB4Q34369481-35654530-D3A7-45A9-AEDA-065BD99DC734Q34490790-94F2D9C0-6DF0-408F-A9F5-9F25A8B6E904Q34770962-3DB1FCD5-09A1-4A7B-92BE-A2F97D05BB4BQ35118650-3B293FBE-3BCE-4EC2-8F24-E472B1B3CBA1Q35635330-DD94CC31-9BBE-4D8B-90F6-7D03FCF07DD1Q35844039-49B49908-A802-4E09-916C-62A49C848431Q36003833-DD502640-F85B-471A-9604-9C7F21955CC2Q36634469-D8FAEF61-4511-4D17-AADA-E1CEF688C90DQ36677039-CA326BEF-10B3-4CCB-B38D-CD58D52B3CD0Q36769578-916A2FAD-112B-46B7-A642-D8ACC805A61CQ36946621-3BA4B786-E908-4EF2-B598-52AE3A9D7684Q36950304-4BAC91E7-DA21-4F5D-B76D-6E9106A1C6E6Q37162585-BDD90C36-4045-48C2-9E70-6A222E3E1F5DQ37277970-40159927-601D-4F2A-A164-C95543DEC47BQ37398690-700BA41A-C34F-4CF3-B92D-11B18976F2E5Q37460852-D3CADD11-5A42-4E7F-A01D-59D5A619F3D9Q37688628-3C190367-1286-4C28-96F5-8D6853B827D9
P50
description
onderzoeker
@nl
name
Jeanette Schulz-Menger
@ast
Jeanette Schulz-Menger
@en
Jeanette Schulz-Menger
@es
Jeanette Schulz-Menger
@sl
type
label
Jeanette Schulz-Menger
@ast
Jeanette Schulz-Menger
@en
Jeanette Schulz-Menger
@es
Jeanette Schulz-Menger
@sl
prefLabel
Jeanette Schulz-Menger
@ast
Jeanette Schulz-Menger
@en
Jeanette Schulz-Menger
@es
Jeanette Schulz-Menger
@sl